DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Vatalanib is an investigational drug.
There have been 23 clinical trials for Vatalanib. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2003.
The most common disease conditions in clinical trials are Central Nervous System Neoplasms, Carcinoid Tumor, and Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Novartis, and Bayer.
Recent Clinical Trials for Vatalanib
|Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer||The Affiliated Hospital of the Chinese Academy of Military Medical Sciences||Phase 1/Phase 2|
|Apatinib for Metastatic Esophageal Cancer.||Hangzhou Cancer Hospital||Phase 2|
|Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors||National Cancer Institute (NCI)||Phase 1|